TLR3 and Alzheimer disease: 10.2% of lncRNAs (1733 out of 16967) and 15.1% of protein-coding mRNA transcripts (1760 out of 11632) were significantly differentially expressed (absolute fold-change ≥5, P value ≤ 0.05) between TLR3-activated AD-MSCs and control AD-MSCs.